Literature DB >> 25715089

Cardiac remodeling in response to chronic iron deficiency: role of the erythropoietin receptor.

Yoshiro Naito1, Hisashi Sawada, Makiko Oboshi, Toshihiro Iwasaku, Yoshitaka Okuhara, Daisuke Morisawa, Akiyo Eguchi, Shinichi Hirotani, Toshiaki Mano, Takeshi Tsujino, Tohru Masuyama.   

Abstract

OBJECTIVE: Anemia is a common comorbidity of patients with heart failure, and iron deficiency is known as one of the causes of anemia in heart failure. Recent studies have shown that iron deficiency alone, without overt anemia, is associated with poor outcomes in patients with heart failure. Thus, to minimize the mortality in patients with heart failure, it is important to understand the link between iron deficiency and cardiac function. Chronic untreated iron deficiency results in cardiac remodeling, and we have previously reported that erythropoietin (Epo) and cardiac Epo receptor (EpoR) signaling may be associated with its remodeling. However, the link between EpoR signaling and its remodeling remains to be elucidated. Herein, we investigated the role of EpoR signaling on cardiac remodeling in response to chronic iron deficiency.
METHODS: Wild-type mice and transgene-rescued EpoR-null mutant mice, which express EpoR only in the hematopoietic lineage (EpoR-restricted mice), were fed with either a normal or an iron-restricted diet, and the molecular mechanisms were investigated.
RESULTS: Dietary iron restriction gradually induced anemia, Epo secretion, and cardiac hypertrophy in wild-type mice. In contrast, EpoR-restricted mice fed with an iron-restricted diet exhibited anemia, left ventricular dilatation, and cardiac dysfunction compared with wild-type mice. Interestingly, altered cardiac mitochondrial biogenesis was observed in EpoR-restricted mice following iron deficiency. Moreover, cardiac p53 expression was increased in EpoR-restricted mice compared with wild-type mice following iron deficiency.
CONCLUSION: These data indicate that EpoR signaling is associated with cardiac remodeling following chronic iron deficiency.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25715089     DOI: 10.1097/HJH.0000000000000547

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

1.  Novel insights into renovascular hypertension and cardio-renal protection by iron restriction.

Authors:  Atsushi Tanaka; Koichi Node
Journal:  Hypertens Res       Date:  2016-09-08       Impact factor: 3.872

2.  Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy.

Authors:  Ali M Tabish; Mohammed Arif; Taejeong Song; Zaher Elbeck; Richard C Becker; Ralph Knöll; Sakthivel Sadayappan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-04-26       Impact factor: 4.733

Review 3.  Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms.

Authors:  Tetsuji Miura; Tatsuya Sato; Toshiyuki Yano; Akira Takaguri; Takayuki Miki; Noritsugu Tohse; Keitaro Nishizawa
Journal:  Cardiovasc Drugs Ther       Date:  2022-02-12       Impact factor: 3.727

4.  Association between plasma B-type natriuretic peptide and anaemia in heart failure with or without ischaemic heart disease: a retrospective study.

Authors:  Mitsutoshi Tominaga; Makoto Kawai; Kosuke Minai; Kazuo Ogawa; Yasunori Inoue; Satoshi Morimoto; Toshikazu Tanaka; Tomohisa Nagoshi; Takayuki Ogawa; Michihiro Yoshimura
Journal:  BMJ Open       Date:  2019-03-04       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.